Activation of the NF-κB-mediated inflammatory pathway in glial cells is thought to contribute to an accelerated disease progression in neurodegenerative diseases such as ALS and, therefore, differences in this pathway might hold important clues for the selective vulnerability of different neuronal cell populations in disease. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.